Opdualag (nivolumab and relatlimab-rmbw) — Medica

Initial criteria

• Patient is age ≥ 12 years
• Patient weighs ≥ 40 kg
• Patient has unresectable or metastatic disease OR medication is used for neoadjuvant therapy
• Medication is prescribed by or in consultation with an oncologist

Approval duration

1 year